Medicine and Dentistry
Patient
100%
Pediatrics Patient
29%
Child
27%
Hematopoietic Stem Cell Transplantation
25%
Combination Therapy
23%
Survival Rate
19%
Chemotherapy
18%
Overall Survival
17%
Donor
15%
Analysis
15%
Age
15%
Acute Lymphoblastic Leukemia
14%
Cyclophosphamide
14%
High Dose Chemotherapy
14%
Diagnosis
13%
Transplantation
12%
Inpatient
12%
Event Free Survival
11%
Retrospective Study
11%
Follow up
11%
Experience
10%
Complication
10%
Childhood
10%
Germinoma
10%
Case Report
10%
Autologous Stem Cell Transplantation
10%
Radiation Therapy
9%
Hospital
9%
Spontaneous Remission
8%
Cells
8%
Toxicity
8%
Central Nervous System
7%
Hepatic Veno-Occlusive Disease
7%
Lymphoma
7%
Prospective Study
7%
Cytomegalovirus Infection
7%
Childhood Cancer
7%
Busulfan
6%
Posttransplant Lymphoproliferative Disease
6%
Stem Cell Transplant
6%
Hemophagocytic Syndrome
6%
Imatinib
6%
Acute Leukemia
6%
Hematopoietic Stem Cell
6%
Young Adult
6%
Retinoblastoma
6%
T Cell
6%
Vein Occlusion
6%
Shear Wave Elastography
6%
Relapse
6%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacokinetics
14%
Busulfan
10%
Toxicity
9%
Chemotherapy
9%
Acute Lymphoblastic Leukemia
8%
Neutropenia
8%
Imatinib
6%
Fludarabine
6%
Malignant Neoplasm
5%
Solid Malignant Neoplasm
5%
Pharmacodynamics
5%